{"meshTags":["Adenocarcinoma","Antineoplastic Agents, Hormonal","Breast Neoplasms","Carcinoma in Situ","Carcinoma, Ductal, Breast","Female","Humans","Lymphatic Metastasis","Mastectomy, Radical","Middle Aged","Sentinel Lymph Node Biopsy","Tamoxifen","United States"],"meshMinor":["Adenocarcinoma","Antineoplastic Agents, Hormonal","Breast Neoplasms","Carcinoma in Situ","Carcinoma, Ductal, Breast","Female","Humans","Lymphatic Metastasis","Mastectomy, Radical","Middle Aged","Sentinel Lymph Node Biopsy","Tamoxifen","United States"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article","Multicenter Study","Validation Studies"],"abstract":"The regional lymph node status is the most powerful predictor of survival in women with invasive breast cancer.","title":"Sentinel lymph node biopsy for breast cancer.","pubmedId":"11510518"}